Telix Pharmaceuticals Lim... (TLX)

NasdaqGS: TLX · 실시간 가격 · USD

11.88

+0.15 (1.28%)

종가 기준: Aug 18, 2026, 8:00 PM

12.20

+2.69%

프리마켓: 9:04 AM

1.28% (1D)

데이터 없음

매수호가	11.78
시가총액	4.02B
매출 (ttm)	803.79M
순이익 (ttm)	-7.13M
베타	0.60
EPS (ttm)	-0.02
P/E (ttm)	n/a
선행 P/E	64.47
P/B (ttm)	9.69
P/S (ttm)	5.01
Earnings Date	n/a

매도호가	10.32
거래량	42,691
평균 거래량 (20일)	158,151
시가	11.87
전일 종가	11.73
일중 범위	11.84 - 11.98
52주 범위	6.28 - 12.60
애널리스트	n/a
목표주가	n/a
배당	n/a
배당락일	n/a

TLX 소개

Telix Pharmaceuticals Limited, a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals. The company operates through three segments: Precision Medicine, Therapeutics, and Manufacturing Solutions. Its lead therapeutic product candidate is TLX591, a lutetium-labeled radio antibody-drug conjugate (rADC), which is in a Phase 3 clinical trial in patients with adv...

[더 보기]

산업 Biotechnology

섹터 Healthcare

IPO 일자 Nov 14, 2024

직원 수 1,120

상장 거래소 NasdaqGS

티커 TLX

웹사이트 https://telixpharma.com

전체 기업 정보

재무 실적

2025년 Telix Pharmaceuticals의 매출은 803.79M로, 전년 516.55M 대비 55.61% 증가했습니다. 순이익은 -7.13M로, -121.15% 감소했습니다.

재무제표

뉴스

2주 전 · Simply Wall St.

Why Regeneron (REGN) Is Up 6.7% After Mixed Q2 Results And New Telix Oncology Deal

Regeneron Pharmaceuticals reported past second-quarter 2026 results with revenue rising to US$4,290.7 million from US$3,675.6 million a year earlier, while net income slipped to US$1,296.9 million and...

2주 전 · Pharma Voice

How Telix landed a $2.1 billion radiopharma deal with Regeneron

Regeneron tapped the Aussie biotech to enter the radiopharma market with a multi-pronged agreement.

4주 전 · Zacks

Does Telix Pharmaceuticals Limited (TLX) Have the Potential to Rally 86.17% as Wall Street Analysts Expect?

The average of price targets set by Wall Street analysts indicates a potential upside of 86.2% in Telix Pharmaceuticals Limited (TLX). While the effectiveness of this highly sought-after metric is que...

1개월 전 · Pharmaceutical Technology

Telix opens radiopharmaceutical facility in Australia for cancer treatment

The facility aims to address manufacturing capacity challenges and bring production and patient administration closer together.

2개월 전 · Insider Monkey

Telix Pharmaceuticals (TLX), United Imaging Healthcare Form Strategic Theranostics Research Partnership

Telix Pharmaceuticals Limited (NASDAQ:TLX) is one of the best new stocks to buy with the huge upside potential. On June 2, Telix Pharmaceuticals and United Imaging Healthcare signed an MoU to establi...

2 페이지 중 1

Telix Pharmaceuticals Lim... (TLX)

TLX 소개

재무 실적

어닝 서프라이즈

Why Price Moved